• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 10310
Device Problems Contamination (1120); Device Disinfection Or Sterilization Issue (2909)
Patient Problem Unspecified Infection (1930)
Event Date 11/19/2015
Event Type  Injury  
Manufacturer Narrative
Investigation: the run data file was analyzed for this event.The signals in the run data file for this procedure show the system was operating as intended and there were no procedure-related events in which bacteria could have been introduced.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported a stem cell collection was not sterile and the patient required prophylactic antibotic treatment due to the contamination.Due to eu personal data protection laws, the patient information is not available from thecustomer.Donor gender and weight were obtained from the run files.The disposable kit is not available for return, because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: a review of the device history record for this unit showed no irregularities during manufacturing that were relevant to this issue.The customer reported that the culture was positive for propionibacterium acnes.Per literature review, propionibacterium acnes is a gram positive skin bacteria that is involved in acne.During investigation of other reported events, it was found that they currently have a 20% bacterial contamination rate of their apheresis products (typically the contamination rate for autologous products is around 0-4%).This was also discussed at length, and is most likely due to improper use of the central lines.Per internal documentation, the phenomenon of bacterial contamination in blood products is known to occur.Given the nature of micro organisms on human skin and the mechanical act of piercing the skin, it is not possible to completely eliminate bacterial contamination from occurring.The devices terumo bct manufactures to collect, separate, and store blood products are terminally sterilized to a sterility assurance level (sal) of
 
Event Description
Per follow-up with the customer, no medical intervention was necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
matthew bickford
10810 w collins ave
lakewood, CO 80215
3032052494
MDR Report Key5414783
MDR Text Key37617543
Report Number1722028-2016-00067
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
PMA/PMN Number
BK140191
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/01/2017
Device Catalogue Number10310
Device Lot Number08Y3119
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/19/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Weight67
-
-